ENVVENO MEDICAL CORP (NVNO) Stock Income Statement
NASDAQ:NVNO - Nasdaq - US29415J1060 - Common Stock - Currency: USD
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 24.87M | 24.00M | 25.00M | 24.93M | 16.89M | |||
| Research and Development | 11.82M | N/A | 13.58M | 9.91M | 5.73M | |||
| Selling, General, and Administrative Expenses | 12.95M | 11.00M | 11.00M | 14.82M | 11.06M | |||
| Operating Income | -24.87M | -24.00M | -25.00M | -24.93M | -16.89M | |||
| Interest Income/Expense | 1.80M | N/A | 1.72M | 260.00K | 20.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | 30.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | 310.00K | |||
| Income Before Taxes | -23.07M | -22.00M | -24.00M | -24.67M | -16.53M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -23.07M | -22.00M | -24.00M | -24.67M | -16.53M | |||
| EBITDA | -24.37M | -23.47M | -24.45M | -24.72M | -16.74M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.21 | -1.29 | -2.00 | -2.20 | -1.90 | |||
| Non GAAP EPS | -1.20 | -1.27 | -1.96 | -2.19 | -1.96 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD